...

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

【24h】

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

机译：高风险急性髓细胞白血病和骨髓增生异常综合征同种异体造血干细胞移植后预防性阿扎胞苷和供体淋巴细胞输注的前瞻性II期研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共6页
作者
Guillaume Thierry; Yakoub-Agha Ibrahim; Tabrizi Reza; Borel Cecile; Chevallier Patrice; Magro Leonardo; Vigouroux Stephane; Peterlin Pierre; Garnier Alice; Rubio Marie-Therese; Huynh Anne; Milpied Noel; Moreau Philippe; Mohty Mohamad;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome [J] . Guillaume Thierry, Malard Florent, Magro Leonardo, Bone marrow transplantation . 2019,第11期

机译：预防性低剂量氮杂硝乙汀和供体淋巴细胞输注的前瞻性期II研究在同种异体造血干细胞移植治疗高危急性髓性白血病和骨髓增生术综合征
2. Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation [J] . Takami Akiyoshi, Yano Shingo, Yokoyama Hiroki, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2014,第11期

机译：供体淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓样白血病：日本造血细胞移植协会成人急性髓样白血病工作组的回顾性分析
3. Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study [J] . Voso M. T., Leone G., Piciocchi A., Annals of oncology: official journal of the European Society for Medical Oncology . 2017,第7期

机译：氮杂硝基桥桥桥桥后异种干细胞移植的可行性，低爆炸症急性髓性白血病：BMT-AZA前瞻性研究结果
4. Adhesion of Hematopoietic Stem Cells and Acute Myeloid Leukemia Cell Lines to Functionalized Surfaces of P-Selectin and Cd34 Antibody [C] . Michael R. King, Jane L. Liesveld, Nichola Charles International Symposium on Runaway Reactions, Pressure Relief Design and Effluent Handling American Institute of Chemical Engineers/American Chemical Society Management Conference . 2005

机译：造血干细胞的粘附和急性髓性白血病细胞系对P-Selectin和CD34抗体的官能化表面
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Phase I Study of Azacitidine following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation [O] . Armin Ghobadi, Jaebok Choi, Mark A. Fiala, -1

机译：供体淋巴细胞输注后阿扎胞苷用于异基因干细胞移植后复发的急性髓细胞性白血病的I期研究
7. Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548) [O] . Schroeder T., Czibere A.G., Kröger N., 2011

机译：将阿扎胞苷（Vidaza®，Aza）和供体淋巴细胞输注（DLI）结合作为异基因造血干细胞移植（allo-SCT）复发的急性髓样白血病（AML）或骨髓增生异常综合征（MDS）复发的患者（PTS）的首次抢救治疗： Azarela试用版的中期分析（NCT-00795548）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号